In recent years, there has been a growing interest in the use of autologous therapies, such as autologous eye drops, for the treatment of ocular surface injuries and diseases. These therapies utilize a patient's own blood to create a personalized treatment solution. The Tums Top (Top Achievements of Tehran University of Medical Sciences) program recently showcased the production process of autologous eye drops at Farabi Hospital, a leading ophthalmology center affiliated with Tehran University of Medical Sciences. This innovative approach offers a promising new option for patients suffering from severe dry eye and other ocular surface conditions.